FDA Rejects CKD Drug Tenapanor
Photo by Paweł Czerwiński on Unsplash

FDA Rejects CKD Drug Tenapanor

Despite drug developers' best efforts, the path to approval is not always easy. Ask biotechnology company Ardelyx, whose potential treatment option tenapanor was recently rejected by the FDA. According to…

Continue Reading FDA Rejects CKD Drug Tenapanor
Farxiga Now FDA-Approved to Treat CKD
https://unsplash.com/photos/_jbClosDsD4

Farxiga Now FDA-Approved to Treat CKD

According to BioSpace, Farxiga (dapagliflozin), a treatment for patients with chronic kidney disease (CKD) and a risk of progression, recently became FDA-approved. Developed by AstraZeneca, the therapy is specifically designed…

Continue Reading Farxiga Now FDA-Approved to Treat CKD
Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021
rawpixel / Pixabay

Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021

  At the Endocrine Society's Annual Meeting, or ENDO 2021, Amolyt Pharma ("Amolyt") shared positive clinical data from a Phase 1 clinical trial evaluating AZP-3601 for patients with hypoparathyroidism. Although…

Continue Reading Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021
Four New Rare Disease Studies Receive $19 Million in Funding
source: pixabay.com

Four New Rare Disease Studies Receive $19 Million in Funding

The Patient-Centered Outcomes Research Institute (PCORI) has announced that it will be contributing funding for four new studies focused on four different rare diseases. The funding will top out at…

Continue Reading Four New Rare Disease Studies Receive $19 Million in Funding
Chronic Kidney Disease Treatment is More Widely Available in Tennessee and Alabama
qimono / Pixabay

Chronic Kidney Disease Treatment is More Widely Available in Tennessee and Alabama

Monogram Health has recently announced that they will be expanding their collaboration with Humana Inc. to provide greater access to chronic kidney disease and end-stage renal disease treatment. They will…

Continue Reading Chronic Kidney Disease Treatment is More Widely Available in Tennessee and Alabama
Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain
source: pixabay.com

Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain

A study has recently highlighted the fact that patients who have type 2 diabetes are more susceptible to chronic kidney disease (CKD), and as a result, cardiac issues. This study…

Continue Reading Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain
Unmet Needs in the Treatment of Certain Glomerular Diseases
source: pixabay.com

Unmet Needs in the Treatment of Certain Glomerular Diseases

by Lauren Taylor from In The Cloud Copy Nephrologists worldwide have shown that there is a huge unmet need when it comes to the treatment of various glomerular diseases, in…

Continue Reading Unmet Needs in the Treatment of Certain Glomerular Diseases
Year Two of This Alport Syndrome Trial Concludes with Encouraging Findings
source: pixabay.com

Year Two of This Alport Syndrome Trial Concludes with Encouraging Findings

According to a story from GlobeNewswire, the biopharmaceutical company Reata Pharmaceuticals, Inc., recently announced that year two of its phase 3 clinical trial has been completed. This trial is testing…

Continue Reading Year Two of This Alport Syndrome Trial Concludes with Encouraging Findings
Data from Roxadustat Program for Anemia of CKD Shared at ASN Kidney Week 2020
source: pixabay.com

Data from Roxadustat Program for Anemia of CKD Shared at ASN Kidney Week 2020

In late October, the American Society of Nephrology (ASN) held the ASN Kidney Week 2020 Reimagined. During the conference, biopharmaceutical company FibroGen shared two posters (abstracts PO2625 and PO2626) regarding…

Continue Reading Data from Roxadustat Program for Anemia of CKD Shared at ASN Kidney Week 2020
FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment
stevepb / Pixabay

FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment

The FDA has recently granted the Breakthrough Therapy designation to FARXIGA, a chronic kidney disease treatment created by AstraZeneca. This designation will allow for a quicker development, which will hopefully…

Continue Reading FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment
American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign
source: pixabay.com

American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign

According to a press release from the American Kidney Fund (AKF), the organization, which is dedicated to fighting kidney disease, has partnered with the biotech company Sanofi Genzyme in a…

Continue Reading American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign